stockrowProgyny, Inc.
PGNY Healthcare Healthcare Plans
Progyny, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.3 billion, up 10.4% from fiscal 2024.
- Revenue
- +8.91%
- EPS
- +115.3%
- Free cash flow
- +2.72%
Quarter to September 2026, against a year earlier
Follow PGNY
Alert me
Progyny, Inc. (PGNY) Return on equity
Progyny, Inc.'s return on equity over the twelve months to 30 September 2026 was 18.7%, up 6.2 percentage points from fiscal 2025 (12.5%). Over the past ten years it has ranged from −89.5% (fiscal 2019) to 33.0% (fiscal 2020); the current reading is higher than 56% of that period. That is above the Healthcare Plans industry median of 13.6% and above the Healthcare sector median of −26.0%.
Return on equity, annual
Embed this chart
Annual newest first
| Period | Return on equity | Change (points) |
|---|---|---|
| FY2025 | 12.5% | 1.34 |
| FY2024 | 11.1% | (2.20) |
| FY2023 | 13.3% | 3.68 |
| FY2022 | 9.66% | (21.75) |
| FY2021 | 31.4% | (1.63) |
| FY2020 | 33.0% | 122.51 |
| FY2019 | −89.5% | (88.78) |
| FY2018 | −0.69% | (14.67) |
| FY2017 | 14.0% | — |
Against its own ten years
Return on equity against peers
| Company | Return on equity |
|---|---|
| OSCR Oscar Health, Inc. compare | 52.6% |
| PGNY Progyny, Inc. | 18.7% |
| CI Cigna Group compare | 14.0% |
| ALHC Alignment Healthcare, Inc. compare | 13.2% |
| ELV Elevance Health, Inc. compare | 11.6% |
| CNC Centene Corporation compare | 6.74% |
| HUM Humana Inc. compare | 6.65% |
| CLOV Clover Health Investments, Corp. compare | 3.40% |
| MOH Molina Healthcare, Inc compare | −1.15% |
| Healthcare Plans industry median | 13.6% |
| Healthcare sector median | −26.0% |
| Market median | 1.01% |
What Return on equity is
ROE shows how much profit a company earns for its shareholders on the equity they have in the business.
Annual: Net Income Allotted to Shareholders ÷ Average Common Equity; TTM: Net Income Allotted to Shareholders ÷ Average Common Equity (latest quarter)
More on PGNY
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement